Word: orrin
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Even then, her renomination became a referendum on the past. At one point, Senator Orrin Hatch took the last minutes of his testimony against Johnsen to praise the authors of the Bush-era memos, John Yoo and Jay Bybee, calling them "two brilliant guys" and "very excellent people." Conversely, Democrats split their time between urging support for Johnsen and condemning the Bush lawyers who came before her. The vote to again send her nomination for a floor vote was on strict party lines. (See four myths about Supreme Court nominees...
...smaller, more conservative party base. After Specter's party switch, Toomey was down in the polls by 20 points against Specter in a general-election matchup. The GOP scouted unsuccessfully for a more moderate candidate, like popular former governor Tom Ridge. So dark were Toomey's prospects that Senator Orrin Hatch, the vice chairman of the National Republican Senatorial Committee, lamented to Politico.com, "I don't think there is anybody in the world who believes he can get elected Senator there." (See pictures from the Pennsylvania Senate race...
...middle are fed up with the partisan gridlock in D.C." Though many of the provisions in the smaller bill are bipartisan - such as one that provided payroll tax breaks to companies with new hires co-authored by New York's Chuck Schumer, the No. 3 Senate Democrat, and Orrin Hatch, a Utah Republican - the process by which Reid yanked the bill made for a lot of bitter feelings. "To squander [the Baucus-Grassley bill] is partisan politics trumping everything else," Hatch told ABC News Friday...
...York Times reported yesterday that Utah Republican Sen. Orrin Hatch is also planning to introduce an equally stringent amendment to the Senate bill...
...policymakers look for ways to control health-care costs, the price of biologics is drawing more and more scrutiny. The obvious model for bringing in competition is a 1984 law that Waxman wrote with Republican Senator Orrin Hatch. It lowered the regulatory obstacles that prevented generic drugs from making their way to market. At the time, it was expected that fast-tracking the approval of "bioequivalent" drugs would bring down medical costs by $1 billion a year. But with generics now accounting for more than 70% of prescriptions dispensed in the U.S., "the actual savings have exceeded our wildest expectations...